A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

This study has been terminated.

( Program discontinued )

Study NCT00231634 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: September 30, 2005 Last Updated: May 16, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2002
Estimated Primary Completion Date:	No date given